ロード中...
A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations
With advancement of technologies such as genomic sequencing, predictive biomarkers have become a useful tool for the development of personalized medicine. Predictive biomarkers can be used to select subsets of patients, which are most likely to benefit from a treatment. A number of approaches for su...
保存先:
| 出版年: | Pharm Stat |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6772173/ https://ncbi.nlm.nih.gov/pubmed/31270933 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pst.1951 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|